Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01747772 · ClinicalTrials.gov registry record · NA
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT01747772: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01747772 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01747772, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
HYPOTHESIS: The investigators hypothesize that sonoelastography (SE) will provide accurate quantitative measurements that can be used to stage liver fibrosis in patients with chronic liver disease. 1. To measure liver stiffness with sonoelastography in adults with suspect diffuse liver disease who will undergo non-focal liver biopsy as part of their routine clinical care 2. To assess the sensitivity and specificity of sonoelastography for the detection and staging of liver fibrosis 3. To evaluate the effect of steatosis and inflammation on the estimation of liver fibrosis using sonoelastography
Interventions
- DEVICE Shear Wave Sonoelastography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01747772
The ClinicalTrials.gov registry entry for NCT01747772 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shear Wave Sonoelastography is the first listed.
NCT01747772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01747772 about?
NCT01747772 is a clinical study titled "Sonoelastography: Ultrasound Method to Measure Liver Fibrosis". HYPOTHESIS: The investigators hypothesize that sonoelastography (SE) will provide accurate quantitative measurements that can be used to stage liver fibrosis in patients with chronic liver disease. 1. To measure liver stiffness with sonoelastography in adults with suspect diffuse liver disease who ...
What is the current status of trial NCT01747772?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2010-02. Estimated completion is 2014-02-14.
What interventions are being tested in trial NCT01747772?
The interventions under investigation include: Shear Wave Sonoelastography (DEVICE).
Who is sponsoring clinical trial NCT01747772?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.